Engineers Gate Manager’s Vaxcyte PCVX Stock Holding History

Engineers Gate Manager’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Buy	+32,784	New	+$1.78M	0.02%	716
2025 Q4	–	Sell	-114,660	Closed	-$4.13M	–	2429
2025 Q3	$4.13M	Sell	114,660 -46,148	-29%	-$1.53M	0.05%	454
2025 Q2	$5.23M	Buy	160,808 +64,111	+66%	+$2.1M	0.07%	376
2025 Q1	$3.65M	Buy	96,697 +38,008	+65%	+$3.04M	0.06%	447
2024 Q4	$4.8M	Buy	58,689 +54,199	+1,207%	+$5.38M	0.08%	321
2024 Q3	$513K	Buy	+4,490	New	+$405K	0.01%	1370
2024 Q2	–	Sell	-5,554	Closed	-$379K	–	2162
2024 Q1	$379K	Buy	+5,554	New	+$385K	0.01%	1345
2021 Q1	–	Sell	-8,840	Closed	-$235K	–	2053
2020 Q4	$235K	Buy	+8,840	New	+$329K	0.01%	1429

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Engineers Gate Manager's PCVX Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Vaxcyte (PCVX) in Q2 2026: 32,784 shares worth $1.91M. The stake represents 0.02% of the portfolio and ranks #716 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in PCVX as recently as Q3 2025.

Engineers Gate Manager first reported a position in PCVX in Q4 2020 and has held it in 8 quarters since. The position peaked at $5.23M in Q2 2025. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Engineers Gate Manager held 32,784 shares of Vaxcyte worth $1.91M as of Q2 2026.
Vaxcyte was a new Engineers Gate Manager position in Q2 2026.
Vaxcyte made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #716 holding.
Engineers Gate Manager first reported a position in Vaxcyte in Q4 2020 and has held it in 8 quarters since.
Engineers Gate Manager's Vaxcyte position peaked at $5.23M in Q2 2025.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.